Recombinant Pig Probable ATP-dependent RNA helicase DDX4 (DDX4), partial, refers to a recombinant form of the DDX4 protein, which is a DEAD-box RNA helicase. DDX4 is primarily known for its role in germline cells but has been implicated in various cellular processes, including RNA metabolism and cancer progression. The term "partial" suggests that this recombinant protein may not include the full-length sequence of DDX4.
DDX4 is an RNA helicase that plays a crucial role in RNA metabolism. It is highly expressed in germline cells but can also be re-expressed in somatic cells, contributing to cancer progression. In cancer cells, DDX4 has been shown to enhance chemoresistance, cell motility, and mRNA translation, which are critical factors in tumor growth and survival .
Chemoresistance: DDX4 expression increases resistance to chemotherapeutic agents like cisplatin in small cell lung cancer (SCLC) cells. This resistance is associated with upregulated proteins involved in DNA repair and immune responses .
Cell Motility: DDX4 enhances cell motility, which is a key feature of the epithelial-to-mesenchymal transition (EMT), promoting cancer cell invasion and metastasis .
RNA Granules: DDX4 forms cytoplasmic granules resembling germ granules in cancer cells. These granules regulate gene expression and promote malignant properties .
Alternative Splicing: DDX4 influences the alternative splicing landscape of genes involved in cancer growth and invasiveness .
Other DEAD-box helicases, such as DDX6 and DDX10, also play significant roles in RNA metabolism and disease progression. For example, DDX6 is involved in the formation of P-bodies and mRNA decapping , while DDX10 modulates α-synuclein toxicity in Parkinson's disease .
| Helicase | Function | Disease Association |
|---|---|---|
| DDX4 | Enhances chemoresistance, cell motility, and mRNA translation in cancer cells. Forms cytoplasmic granules. | Cancer progression |
| DDX6 | Involved in P-body formation, mRNA decapping, and autophagy regulation. | Not directly linked to cancer |
| DDX10 | Modulates α-synuclein toxicity in Parkinson's disease. | Parkinson's disease |
| Feature | Description |
|---|---|
| Source | Recombinant pig |
| Function | ATP-dependent RNA helicase activity |
| Role | Potential involvement in RNA metabolism and cancer progression |
| Form | Partial sequence of DDX4 |
STRING: 9823.ENSSSCP00000026827
UniGene: Ssc.42782
DDX4, also referred to as vasa homolog in some species, is an evolutionarily conserved ATP-dependent RNA helicase that is exclusively expressed in the germ cell lineage . As an RNA helicase, DDX4 functions to unwind RNA secondary structures in an ATP-dependent manner, playing crucial roles in RNA metabolism, translation regulation, and germ cell development. In mammalian species, DDX4 has been implicated in various aspects of germline development, including germ cell specification, proliferation, and differentiation . The protein contains characteristic DEAD-box motifs that are essential for its ATPase and helicase activities, which contribute to its fundamental role in germline maintenance and function.
Multiple complementary approaches should be employed to reliably detect DDX4 in experimental systems. Immunological methods using antibodies against specific epitopes of DDX4 are commonly used, including immunohistochemistry, immunofluorescence, and flow cytometry . For mRNA detection, RT-PCR, RNA-seq, and in situ hybridization techniques are valuable. When working with recombinant DDX4, researchers can incorporate epitope tags (such as FLAG, His, or Avi-tag) to facilitate detection and purification . For cell surface DDX4 detection, non-permeabilizing conditions must be maintained during antibody staining to prevent antibodies from accessing intracellular epitopes. When studying recombinant pig DDX4, it's crucial to validate antibody specificity, as cross-reactivity can occur between species, leading to false positive results.
When using antibodies against DDX4 for cell isolation, several critical methodological considerations must be addressed:
Epitope specificity: Use antibodies that target specific epitopes, particularly the C-terminus which has been reported to be exposed on the cell surface of certain cell populations .
Tissue dissociation protocol: The method of tissue dissociation can significantly impact results. Harsh enzymatic treatments (like trypsin) may strip away cell surface proteins, including potential surface-expressed DDX4 . Researchers should use gentler dissociation methods that preserve surface antigens.
Non-permeabilizing conditions: To specifically detect cell-surface DDX4, antibody staining must be performed under non-permeabilizing conditions to prevent access to intracellular DDX4 .
Validation controls: Include appropriate positive and negative controls, such as cells known to express or not express DDX4, respectively. Additionally, test antibody specificity using recombinant DDX4 proteins and competitive binding assays .
Multi-parameter analysis: Combine DDX4 detection with other germ cell markers (like ZBTB16, NANOS2, DAZL for mature germ cells or PRDM1, IFITM3, EPCAM for early germ cells) to properly characterize isolated cell populations .
Functional validation: Perform functional assays to confirm the identity of DDX4-positive isolated cells, such as differentiation assays, transplantation studies, or lineage tracing experiments .
The choice of expression system significantly impacts the properties of recombinant DDX4 in several ways:
| Expression System | Advantages | Limitations | Effects on DDX4 Properties |
|---|---|---|---|
| E. coli | High yield, cost-effective, simple culture conditions | Lacks post-translational modifications, protein may form inclusion bodies | May lack proper folding, potential absence of critical modifications for function, suitable for structural studies |
| Yeast | Eukaryotic post-translational modifications, relatively high yield | Not all mammalian modifications are reproduced | Better folding than E. coli, some glycosylation patterns may differ from mammalian cells |
| Baculovirus/Insect cells | Proper protein folding, mammalian-like modifications | More expensive, longer production time | Improved solubility and functionality, better for enzymatic activity studies |
| Mammalian cells | Native-like post-translational modifications, proper folding | Lowest yield, highest cost, complex culture conditions | Most physiologically relevant form, retains functional characteristics, suitable for localization studies |
When studying potential cell-surface expression of DDX4, mammalian expression systems are preferable as they provide the most physiologically relevant post-translational modifications that might be essential for proper membrane targeting . Transfection experiments have demonstrated that recombinant porcine DDX4 can be expressed on the cell surface, but the mechanisms governing this localization remain to be fully elucidated . The expression system can also affect protein solubility, yield, and helicase activity, which are important considerations for functional studies.
Several experimental approaches have been employed to address contradictory findings regarding DDX4-positive cells:
Transgenic reporter systems: Using Ddx4-Cre;Rosa26 reporter mice to track cells that have activated the Ddx4 gene promoter at any point in development . These systems allow lineage tracing of germ cells but may suffer from "leakiness" of the promoter.
Antibody-based cell isolation: Employing antibodies targeting the C-terminus of DDX4 with FACS (Fluorescence-Activated Cell Sorting) or MACS (Magnetic-Activated Cell Sorting) to isolate cells with extracellular DDX4 expression .
Multi-marker analysis: Characterizing isolated DDX4-positive cells for expression of other germ cell markers (ZBTB16, NANOS2, DAZL) and early primordial germ cell markers (PRDM1, IFITM3, EPCAM) to establish their identity .
Functional validation: Testing the developmental potential of isolated cells through in vitro culture to assess proliferation capacity and in vivo transplantation to evaluate germ cell colony formation or teratoma generation .
Comprehensive methodology comparison: Directly comparing different tissue dissociation methods (e.g., trypsin-based vs. gentler enzymatic approaches) to determine their impact on the detection of DDX4-positive cells .
Cross-species analysis: Examining DDX4-positive cells across different species to determine whether findings are species-specific or evolutionarily conserved .
These approaches have yielded important insights. For instance, crude dispersion of ovaries from Ddx4-Cre;Rosa26 mice may contain immature oocytes that are reporter-positive but incapable of proliferation, potentially explaining some contradictory results . Additionally, studies in porcine testes revealed that cell-surface DDX4-immunoreactive cells might represent a distinct subpopulation different from gonocytes and not actually germ cells at all .
Developing antibodies against porcine DDX4 presents several specific challenges:
Epitope selection: Identifying immunogenic yet specific epitopes that distinguish DDX4 from other DEAD-box helicases is critical. The C-terminus region has been targeted for surface expression studies, but this region must be carefully selected to ensure specificity .
Antibody cross-reactivity: DEAD-box proteins share conserved motifs, increasing the risk of cross-reactivity. Thorough validation using Western blot analysis against multiple DEAD-box proteins is essential to confirm specificity .
Species-specific variations: Despite high conservation across species, subtle amino acid differences between porcine DDX4 and DDX4 from other species necessitate customized antibody development. Commercial antibodies developed against human or mouse DDX4 may not recognize porcine DDX4 with equal affinity .
Conformational epitopes: If antibodies are intended to recognize native protein (particularly for cell surface detection), they must target accessible epitopes in the protein's natural conformation. This requires immunization strategies that preserve protein structure, such as using recombinant protein expressed in mammalian systems .
Validation challenges: Validating antibodies against porcine DDX4 requires proper controls, including DDX4-knockout tissues or cells (which may be difficult to obtain), competitive binding assays, and immunoprecipitation followed by mass spectrometry to confirm target identity .
Optimizing FACS for isolating DDX4-expressing cells requires several technical considerations:
Non-enzymatic tissue dissociation: Use gentle dissociation methods that preserve cell surface epitopes. Harsh enzymes like trypsin can cleave surface proteins, potentially removing the DDX4 epitope from the cell surface .
Antibody selection and validation: Use antibodies targeting the C-terminal region of DDX4, which has been reported to be externalized in certain cell populations. Validate antibody specificity using appropriate positive and negative controls .
Non-permeabilizing staining conditions: Maintain cell membrane integrity during antibody staining to ensure only cell-surface DDX4 is detected. This distinguishes cells with externalized DDX4 (ecDdx4-positive) from those with only cytoplasmic DDX4 .
Multi-parametric sorting strategy: Combine DDX4 staining with other markers to increase specificity:
Viability dyes to exclude dead cells
CD45 to exclude leukocytes
Other germ cell markers to confirm identity
Gating strategy: Implement a hierarchical gating strategy:
| Gating Step | Purpose | Markers |
|---|---|---|
| Debris exclusion | Remove cellular debris | FSC/SSC properties |
| Singlet selection | Exclude cell doublets | FSC-H vs. FSC-A |
| Viability gating | Exclude dead cells | Viability dye negative |
| DDX4 detection | Identify DDX4+ cells | Anti-DDX4 antibody |
| Reporter detection | For transgenic models | Fluorescent protein (e.g., tdTm) |
Sort settings: Use a low-pressure, large-nozzle setting to maintain cell viability, especially for larger cells like oocytes .
In a study using Ddx4-Cre;Rosa26 reporter mice, approximately 3.15% of tdTomato-positive cells were also positive for cell-surface DDX4 expression, representing about 1.83% of total viable cells sorted from the ovaries . This small population highlights the importance of optimized sorting parameters to accurately isolate these rare cells.
When investigating cell-surface expression of DDX4, several essential experimental controls must be implemented:
Antibody specificity controls:
Permeabilization controls:
Expression validation controls:
Functional validation controls:
Reporter controls for transgenic systems:
In one study examining cell-surface DDX4-immunoreactive cells in porcine testes, despite positive antibody staining, these cells expressed negligible DDX4 mRNA and protein levels and lacked other germ cell markers (ZBTB16, NANOS2, DAZL). Instead, they expressed early primordial germ cell markers (PRDM1, IFITM3, EPCAM) . This finding demonstrates the critical importance of comprehensive validation beyond antibody staining alone.
The choice of recombinant expression system significantly impacts studies of DDX4 localization in several key ways:
Post-translational modifications: Different expression systems provide varying post-translational modifications that may be critical for proper DDX4 localization. Mammalian expression systems provide the most physiologically relevant modifications, while bacterial systems lack many of these modifications entirely .
Membrane targeting sequences: The proper processing of potential membrane-targeting sequences in DDX4 depends on the expression system's cellular machinery. Mammalian and insect cell systems are more likely to correctly process these signals compared to bacterial or cell-free systems.
Protein folding: Proper folding of DDX4 is essential for exposing the correct epitopes on the cell surface. Eukaryotic expression systems generally provide superior folding environments compared to prokaryotic systems .
Validation studies: Transfection experiments have demonstrated that recombinant porcine DDX4 can be expressed on the cell surface . Such studies require mammalian expression systems to accurately reflect the potential for cell surface localization.
Fusion tag considerations: The position and nature of fusion tags can impact localization:
| Fusion Tag Position | Potential Impact on DDX4 Localization |
|---|---|
| N-terminal | May interfere with signal sequences or N-terminal localization motifs |
| C-terminal | May mask C-terminal epitopes reported to be exposed on cell surface |
| Internal | May disrupt protein folding and natural localization |
Expression level effects: Overexpression in recombinant systems may cause mislocalization of DDX4 that doesn't reflect its natural distribution. Inducible expression systems with controlled expression levels can help mitigate this issue.
When studying the potential cell-surface expression of DDX4, it's crucial to compare results across multiple expression systems and validate findings using endogenous DDX4 in relevant cell types .
Recombinant DDX4 can serve as a valuable tool to address the ongoing controversy surrounding germline stem cells through several strategic applications:
Epitope mapping studies: Recombinant DDX4 fragments representing different domains can be used to precisely identify which epitopes are recognized by antibodies claiming to detect cell-surface DDX4. This helps determine if antibodies are truly detecting DDX4 or cross-reacting with other proteins .
Competitive binding assays: Purified recombinant DDX4 protein can be used in competition assays to verify the specificity of antibody binding to putative DDX4-expressing cells. If the antibody is specific, pre-incubation with recombinant DDX4 should block binding to cells .
Structure-function studies: Recombinant DDX4 with specific mutations or domain deletions can help identify regions required for potential cell-surface localization, addressing the fundamental question of how a primarily cytoplasmic protein might be expressed on the cell surface .
Development of improved detection reagents: Recombinant DDX4 can be used to generate and validate highly specific monoclonal antibodies or alternative binding proteins (nanobodies, aptamers) that can more definitively identify cell-surface DDX4 .
Protein interaction studies: Tagged recombinant DDX4 can be used to identify binding partners that might facilitate membrane localization or externalization through techniques like pull-down assays, proximity labeling, or yeast two-hybrid screens.
Cell biology verification: Fluorescently tagged recombinant DDX4 can be expressed in relevant cell types to directly observe its localization pattern and trafficking in living cells, potentially revealing mechanisms of cell-surface expression.
By employing recombinant DDX4 in these applications, researchers can provide more definitive evidence regarding the existence and properties of DDX4-expressing germline stem cells, helping to resolve the contradictory findings in the field .
Working with porcine DDX4 requires attention to several species-specific considerations that distinguish it from human or mouse DDX4:
These species-specific considerations highlight the importance of careful experimental design and appropriate controls when studying porcine DDX4, particularly when making comparisons to findings in other species .
Research on DDX4 has significant implications for reproductive biology and fertility preservation:
Identification of germline stem cells: The controversy surrounding DDX4 as a marker for isolating potential oogonial stem cells directly impacts our understanding of ovarian biology and reproductive aging. If mitotically active germ cells expressing DDX4 on their surface truly exist in adult mammalian ovaries, this would challenge the longstanding dogma that females are born with a finite, non-renewable pool of oocytes .
Development of new fertility preservation strategies: If functional oogonial stem cells can be reliably isolated using DDX4 as a marker, they could potentially be cultured, expanded, and used to generate new oocytes. This would revolutionize fertility preservation options for women facing gonadotoxic treatments or age-related fertility decline .
Diagnostic applications: Cell-surface DDX4 expression patterns could potentially serve as diagnostic markers for various reproductive disorders or as predictors of ovarian reserve and response to fertility treatments.
Cross-species insights: Understanding the species-specific nature of DDX4-expressing cells, as observed in the comparison between porcine and mouse testes, informs the translation of animal research findings to human applications .
In vitro gametogenesis: Research on DDX4-expressing cells contributes to efforts to develop protocols for generating functional gametes in vitro, which has profound implications for treating certain forms of infertility.
Fundamental developmental biology: The controversy surrounding cell-surface DDX4 expression challenges researchers to reconsider basic principles of protein localization and cell fate determination in the germline.
The ongoing research to resolve contradictory findings regarding DDX4-expressing cells is critical for determining whether new fertility preservation strategies based on putative germline stem cells are scientifically sound and potentially clinically viable .
Several emerging technologies hold promise for advancing our understanding of DDX4 biology:
Single-cell multi-omics: Integrating single-cell RNA sequencing, ATAC-seq, and proteomics can provide comprehensive profiles of DDX4-expressing cells, revealing heterogeneity within populations and clarifying cell identities beyond what antibody-based methods alone can achieve .
Advanced imaging techniques:
Super-resolution microscopy to visualize DDX4 localization with nanometer precision
Expansion microscopy to physically enlarge specimens for improved visualization of protein localization
Live-cell imaging with fluorescent protein fusions to track DDX4 dynamics in real-time
CRISPR-based approaches:
Precise genome editing to create endogenously tagged DDX4 (avoiding overexpression artifacts)
CRISPRi/CRISPRa for controlled modulation of DDX4 expression
CRISPR screening to identify factors influencing DDX4 localization and function
Proximity labeling techniques: BioID or APEX2 fusions with DDX4 to identify proteins in close proximity, potentially revealing interaction partners involved in membrane trafficking or localization .
Organoid technology: Development of germline organoids to study DDX4 function in a more physiologically relevant 3D context, bridging the gap between 2D culture and in vivo models.
Improved antibody alternatives:
Nanobodies or aptamers with potentially superior specificity for detecting cell-surface DDX4
Antibody engineering to create more specific recognition reagents
In situ protein analysis: Techniques like Immuno-SABER or CODEX for highly multiplexed protein detection in tissues, allowing simultaneous visualization of DDX4 alongside dozens of other markers to better characterize cell populations.
These technologies could help resolve the existing controversies regarding DDX4-expressing cells and provide deeper insights into the fundamental biology of this important germ cell factor .
Several critical questions remain unresolved in DDX4 research:
Mechanism of cell-surface localization: If DDX4 is indeed expressed on the cell surface of certain cells, what is the molecular mechanism that allows a primarily cytoplasmic protein without a conventional signal peptide to be externalized? Does this involve non-conventional secretion pathways, membrane protein partners, or post-translational modifications?
Functional significance of surface expression: What is the biological function of DDX4 on the cell surface, if this localization is genuine? Does it serve as a receptor, participate in cell-cell interactions, or have a completely different role from its cytoplasmic RNA helicase function?
Identity of DDX4-immunoreactive cells: What is the true identity of cells that appear to express DDX4 on their surface? Are they bona fide germline stem cells, early-stage germ cells, or a distinct cell population that cross-reacts with DDX4 antibodies?
Reconciliation of contradictory findings: Why do different experimental approaches yield contradictory results regarding the existence of DDX4-positive germline stem cells? Are methodological differences solely responsible, or are there underlying biological variables?
Species-specific differences: Why are cell-surface DDX4-immunoreactive cells found in some species but not others? What evolutionary or developmental factors account for these differences?
Therapeutic potential: If genuine DDX4-positive germline stem cells exist, can they be reliably isolated, expanded, and differentiated for fertility preservation or restoration?
Antibody specificity resolution: Do antibodies claiming to detect cell-surface DDX4 truly recognize DDX4, or are they binding to a different protein with similar epitopes? How can this be definitively resolved?
Addressing these questions will require rigorous experimental approaches, including the development of new tools and methodologies, and careful consideration of the limitations of existing technologies .